Table 4.

Disorders to Consider in the Differential Diagnosis of Alström Syndrome

DisorderGene(s)MOIClinical Features
Overlapping w/Alström syndromeDistinguishing from Alström syndrome (AS)
Bardet-Biedl syndrome (BBS)>21 genes 1AR 2
  • Rod-cone dystrophy
  • Central obesity
  • Hypogonadism
  • Renal dysfunction
  • Older mean age of onset of visual problems in BBS (8.5 yrs in BBS vs birth - 2 yrs in AS)
  • Polydactyly is common in BBS (not described in AS).
  • Cognitive impairment is common in BBS (normal intelligence in most persons w/AS).
  • Hearing problems are infrequent (~5%) in BBS.
  • Diabetes mellitus is less frequent (5%-10%) in BBS.
Achromatopsia (ACH) ATF6
CNGA3
CNGB3
GNAT2
PDE6C
PDE6H
AR
  • Infantile nystagmus
  • Photophobia
  • Severely ↓ visual acuity
  • Poor or no color discrimination
  • Only the retina is affected in ACH. 3
Retinal findings:
  • Common in ACH; not reported in AS: central outer retinal atrophy/cavitation
  • Common in AS; less common in ACH: retention of central inner retinal layers (foveal immaturity)
Absent in ACH:
  • Cardiomyopathy, obesity, SNHL, T2DM, liver disease, & renal dysfunction
Leber congenital amaurosis / early-onset severe retinal dystrophy (LCA/EOSRD)>30 genes 4AR
AD
  • Retinal degeneration
  • ↓ visual acuity
  • Onset typically in 1st yr of life
  • Nystagmus
  • Photophobia
  • Absence of other organ system involvement in LCA/EOSRD
  • Characteristic oculo-digital sign (repeated eye rubbing, poking, & pressing of eyes) in LCA/EOSRD
Early-onset dilated cardiomyopathy (DCM) (See Dilated Cardiomyopathy Overview.)>25
  • Dilated cardiomyopathy
  • Renal dysfunction (in syndromic forms due to mt defect)
Skeletal muscle disease w/↑ creatine kinase in most syndromic forms of DCM (not observed in AS)
Mitochondrial disorders 5See footnote 5.AR
AD
Mat
  • Cardiomyopathy
  • Sensorineural deafness
  • Optic atrophy
  • Pigmentary retinopathy
  • Diabetes mellitus
  • CNS involvement & muscle weakness may occur in mt disorders (not reported in AS).
  • Late-childhood or adulthood presentation in mt disorders (vs AS, which usually presents in 1st yr of life)

AD = autosomal dominant; AR = autosomal recessive; AS = Alström syndrome; MOI = mode of inheritance; Mat = maternal; mt = mitochondrial; SNHL = sensorineural hearing loss

1.

At least 21 genes are associated with BBS: BBS1, BBS2, ARL6, BBS4, BBS5, MKKS, BBS7, TTC8, BBS9, BBS10, TRIM32, BBS12, MKS1, CEP290, WDPCP, SDCCAG8, LZTFL1, BBIP1, and IFT27.

2.

In some families, pathogenic variants in more than one BBS-related gene may result in a clinical phenotype of BBS. However, such families are difficult to identify and by previous estimations may account for less than 10% of all BBS.

3.
4.

To date, variants in 24 genes account for 70%-80% of individuals with LCA/EOSRD (see Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Overview: Table 2).

5.

Mitochondrial disorders are a heterogeneous group of complex disorders that may be caused by pathogenic variants in mitochondrial DNA or nuclear DNA (see Mitochondrial Disorders Overview).

From: Alström Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.